Clinical trial
Phase I Study of Isotretinoin in Patients With Recessive Dystrophic…
NCT00014729 · University of North Carolina, Other · Completed
Key facts
| NCT number | NCT00014729 |
|---|---|
| Title | Phase I Study of Isotretinoin in Patients With Recessive Dystrophic Epidermolysis Bullosa |
| Lead sponsor | University of North Carolina, Other |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Epidermolysis Bullosa |
| Intervention type | Drug |
| Interventions | isotretinoin |
| Enrollment | 20 |
| Start date | Oct 1, 2000 |
| Completion | Sep 1, 2002 |
| First posted | Apr 11, 2001 |
| Last update posted | Mar 25, 2015 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: